To put that percentage into perspective against currently approved medications: Semaglutide (Wegovy): Produced approximately 14.9% average body weight reduction in its landmark STEP 1 trial over 68 weeks
This can help you feel full sooner and stay full longer after meals
W., Malhotra, A., Ma, J., & Gao, X
It's gentle, sulphate-free, and powered by clinically studied actives including ANAGELINE, caffeine, and biotin making it ideal for those experiencing hair loss linked to GLP-1 medications
Kang S, Amagai M, Bruckner AL, et al
Individuals with obesity and elevated blood pressure Weight loss achieved through GLP-1 therapy often correlates with blood pressure improvements